NETSPOT Farmington is the first Gallium-68 injection, a radioactive diagnostic agent for PET/CT imaging. This scan helps accurately locate and characterize tumors in adult patients with somatostatin-receptor-positive Neuroendocrine Tumors (NETs). NETs are extremely difficult to treat and typically recur after resection or radiation therapy. NETSPOT shows promise in increasing the survival of patients by revealing how far cancer has spread within the body and how aggressive it truly is.
What is NETSPOT?
NETSPOT is the first Gallium-68 injection, a radioactive diagnostic agent for PET/CT imaging. This scan helps accurately locate and characterize tumors in adult patients with somatostatin-receptor-positive Neuroendocrine Tumors (NETs). NETSPOT was FDA-approved in October 2018 and is available to physicians at Netspot Farmington.
Although the NET diagnosis process can take up to 3 years, NET Spot will make it possible for professionals to find cancerous cells with unprecedented accuracy.
How does NETSPOT work?
Netspot Farmington is a radioactive diagnostic agent for PET/CT imaging. This scan helps accurately locate and characterize tumors in adult patients with somatostatin-receptor-positive Neuroendocrine Tumors (NETs). NETS are rare cancers that are often not visible on traditional imaging tests and can be difficult to diagnose with other means. NETs can grow anywhere in the body but typically affect the pancreas, stomach, small bowel, or lungs.
Who can benefit from NETSPOT?
The NETSPOT injection is a radioactive diagnostic agent for PET/CT imaging. It helps accurately locate and characterize tumors in adult patients with somatostatin-receptor-positive Neuroendocrine Tumors (NETs).
How accurate is NETSPOT?
The NETSPOT PET/CT imaging scan is an accurate way to locate and characterize tumors in adult patients with somatostatin-receptor-positive Neuroendocrine Tumors (NETs). PET/CT scans can identify the disease earlier, which improves patient outcomes. This new diagnostic agent is expected to improve cancer treatment for NET patients.
Are there any side effects?
The most common side effects of NETSPOT include nausea, vomiting, fatigue, and diarrhea. These side effects may last from a few hours to several days. There is a very small risk of other serious side effects including allergic reaction, but this is rare. If you notice any unusual symptoms after your injection, you should contact your doctor as soon as possible.
How long does the procedure take?
A scan can take anywhere from 30 minutes to 2 hours, depending on the size of the tumor and if there are any other abnormalities in the body. Patients typically need to drink a small amount of water before the scan as well. NETSPOT is an FDA-approved agent that helps doctors diagnose certain types of tumors without invasive procedures or surgery.
How much does it cost?
NetSpot is a radioactive diagnostic agent for PET/CT imaging. It is the first Gallium-68 injection, and it can accurately locate and characterize tumors in adult patients with somatostatin-receptor-positive Neuroendocrine Tumors (NETs). It costs $600 per dose.
